API / Intermediates

API & Intermediates Compliance Services

Supporting global API and intermediate manufacturers with ICH Q7 / EU GMP Part II readiness reviews, US DMF & European CEP filing compliance, and readiness for GxP shared audits.

  • Market route first
  • Evidence files aligned
  • Less rework before audits
Core Challenges

API & Intermediates Supply Chain Challenges

API export involves frequent customer site audits, complex regulatory filings (DMF/CEP), and strict impurity control thresholds.

ICH Q7 GMP Compliance

Pharma buyers typically require raw material manufacturing and process control to comply with ICH Q7.

Regulatory Filing Barriers

Complex procedures for US FDA DMF submissions/updates and European CEP (Certificate of Suitability) filings.

Impurity & Analytical Controls

Extremely high standards for controlling mutagenic impurities (nitrosamines), solvents, and elemental limits.

Buyer Audits & Shared Audits

Handling repetitive customer audits or preparing for third-party shared audits like Rephine or Qualifyze.

Solutions

Related Compliance Support

QTC supports customer audits, regulatory review readiness, and overseas filing preparation by organizing quality evidence, remediation plans, and critical files.

ICH Q7 / EU GMP Part II Readiness Review

6-8 weeks

For: API sites facing customer audits, pre-approval inspections (PAI), or Rephine/Qualifyze shared audits.

Key Goal

Goal: Eliminate systemic GMP gaps and pass official or buyer site audits

What you get
  • On-site and document gap report aligned with ICH Q7
  • Remediation tracker for utilities validation, lab OOS, and data integrity
  • SOP gap list and revision recommendations
  • On-site inspection response and walkthrough coaching

US DMF / CEP Filing Review & Compilation Support

8-12 weeks

For: API suppliers preparing US DMF or European CEP dossiers who need professional gap reviews.

Key Goal

Goal: Prepare filings that support FDA/EMA technical review and reduce repeated follow-up

What you get
  • CTD Module 3 compliance gap review report aligned with ICH M4
  • Synthesis process studies, impurity profiling, and stability data evaluation
  • Draft recommendations for responding to regulatory deficiency letters
  • DMF annual report documentation prep support

Shared Audit Readiness (Rephine/Qualifyze) Coaching

4-8 weeks

For: API sites preparing for Rephine, Qualifyze, or Rx-360 shared audits to gain multi-buyer recognition.

Key Goal

Goal: Pass shared audits so the report is licensed by multiple international pharma buyers

What you get
  • Mock audit gap report focused on shared audit high-frequency inspection points
  • Remediation plans for data integrity and computerized system validation
  • Airflow pattern, cleaning validation, and mix-up prevention improvements
  • Full facility walkthrough rehearsal and auditor Q&A mock sessions

API Impurity Control & Analytical Method Validation (ICH M7/Q2/Q3D)

4-8 weeks

For: API sites facing nitrosamine risk assessments, ICH Q3D elemental impurity evaluations, or analytical method validation decisions.

Key Goal

Goal: Establish complete impurity control strategies with evidence to pass FDA or EMA regulatory scrutiny

What you get
  • QSAR prediction and ICH M7 classification report for nitrosamines in synthesis routes
  • PDE limit calculations and risk assessments for elemental impurities (As/Cd/Pb/Hg and catalysts)
  • ICH Q2(R1) validation gap analysis and improvement plan for existing analytical methods
  • Analytical validation report drafting and verification of established specifications
Regulatory References

Common Compliance Standards

These standards and registries are key for API exports to the U.S., EU, and Asia-Pacific.

ICH Q7

Global API cGMP standard covering starting materials through packaging.

US DMF (Type II)

Drug Master File submitted to FDA to support formulation ANDA/NDA filings.

CEP (COS)

EDQM certificate verifying API compliance with European Pharmacopoeia.

Rephine / Qualifyze

Leading third-party shared GxP audits accepted globally by major buyers.

FAQ

Frequently Asked Questions

Answering common queries on API export compliance and customer audits.

Sustainability & ESG

Do Your Buyers Also Request ESG Evidence?

Pharma brands and manufacturers increasingly face social audits (EcoVadis, CDP, carbon footprints, human rights) alongside standard GxP/cGMP quality requirements.

Ready to Plan an API Audit or DMF Filing?

Share your synthesis route, impurity challenges, target market, and document status. QTC will design a readiness review or filing review plan.

Contact QTC